Select Publications

Bertero C, Chamberlain WM. Breast cancer diagnosis and its treatment affecting the self: A meta-synthesis. Cancer Nurs 2007;30(3):194-202. Abstract

Boehmke MM, Dickerson SS. The diagnosis of breast cancer: Transition from health to illness. Oncol Nurs Forum 2006;33(6):1121-7. Abstract

Byar KL et al. Impact of adjuvant breast cancer chemotherapy on fatigue, other symptoms, and quality of life. Oncol Nurs Forum 2006;33(1):E18-26. Abstract

Chorn N. Accurate identification of HER2-positive patients is essential for superior outcomes with trastuzumab therapy. Oncol Nurs Forum 2006;33(2):265-72. Abstract

Cuzick J et al. A detailed analysis of the benefits of anastrozole over tamoxifen for venous thromboembolic events (VTEs) after 5 years treatment. San Antonio Breast Cancer Symposium 2006;Abstract 104.

Cuzick J et al. Should aromatase inhibitors be used as initial adjuvant treatment or sequenced after tamoxifen? Br J Cancer 2006;94(4):460-4. Abstract

Dow KH, Kuhn D. Fertility options in young breast cancer survivors: A review of the literature. Oncol Nurs Forum 2004;31(3):E46-53. Abstract

Forbes JF. The use of early adjuvant aromatase inhibitor therapy: Contributions from the BIG 1-98 letrozole trial. Semin Oncol 2006;33(2 Suppl 7):S2-7.  Abstract

Gennari  A et al. A  pooled  analysis  on  the  interaction  between  HER-2  expression  and  responsiveness  of  breast  cancer  to  adjuvant  chemotherapy. San Antonio Breast Cancer Symposium 2007;Abstract  41.

Gobel BH. Nursing considerations of bevacizumab use in multiple tumor types. Oncol Nurs Forum 2007;34(3):693-701. Abstract

Goss PE. Preventing relapse beyond 5 years: The MA.17 extended adjuvant trial. Semin Oncol 2006;33(2 Suppl 7):S8-12. Abstract

Gradishar w et al. Randomized comparison of weekly or every-3-week (q3w) nab-paclitaxel compared to q3w docetaxel as first-line therapy in patients (pts) with metastatic breast cancer (MBC). Proc ASCO 2007;Abstract 1032.

Gradishar WJ et al. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. J Clin Oncol 2005;23(31):7794-803. Abstract

Heidrich SM et al. Symptoms, symptom beliefs, and quality of life of older breast cancer survivors: A comparative study. Oncol Nurs Forum 2006;33(2):315-22. Abstract        

Howell A,et al on behalf of the ATAC Trialists’ Group. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years’ of adjuvant treatment for breast cancer. Lancet 2005;365(9453):60-2. Abstract

Joensuu H et al; FinHer Study Investigators. Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer. N Engl J Med 2006;354(8):809-20. Abstract

Jones SE et al. Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer. J Clin Oncol 2006;24(34):5381-7. Abstract

Jones SE et al. Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer. J Clin Oncol 2005;23(24):5542-51. Abstract

Keller JS. Implementation of a prechemotherapy educational intervention for women newly diagnosed with breast cancer. Clin J Oncol Nurs 2006;10(1):57-60. Abstract

Meneses KD et al. Transition from treatment to survivorship: Effects of a psychoeducational intervention on quality of life in breast cancer survivors. Oncol Nurs Forum 2007;34(5):1007-16. Abstract

Mitchell SA et al. Putting evidence into practice: Evidence-based interventions for fatigue during and following cancer and its treatment. Clin J Oncol Nurs 2007;11(1):99-113. Abstract

Oratz R et al. Impact of Oncotype DX™ on decision making in breast cancer clinical practice. San Antonio Breast Cancer Symposium 2005;Abstract 2049.

Paik S et al. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 2006;24(23):3726-34. Abstract

Paik S et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 2004;351(27):2817-26. Abstract

Partridge AH et al. Adherence with adjuvant anastrozole therapy among women with early stage breast cancer. San Antonio Breast Cancer Symposium 2006;Abstract 4044.

Payne J et al. Biomarkers, fatigue, sleep, and depressive symptoms in women with breast cancer: A pilot study. Oncol Nurs Forum 2006;33(4):775-83. Abstract                   

Perez EA et al. Updated results of the combined analysis of NCCTG N9831 and NSABP B-31 adjuvant chemotherapy with/without trastuzumab in patients with HER2-positive breast cancer. Proc ASCO 2007;Abstract 512.

Piccart-Gebhart MJ et al; Herceptin Adjuvant (HERA) Trial Study Team. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 2005;353(16):1659-72. Abstract

Romond EH et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 2005;353(16):1673-84. Abstract

Rossouw JE et al. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288(3):321-33. Abstract

Schwartzberg LS et al. Variation from clinical guideline recommendations in practice patterns of community based adjuvant hormonal therapy (AHT) in early stage breast cancer (ESBC). San Antonio Breast Cancer Symposium 2006;Abstract 4076.

Slamon D et al. Phase III randomized trial comparing doxorubicin and cyclophosphamide followed by docetaxel (ACT) with doxorubicin and cyclophosphamide followed by docetaxel and trastuzumab (ACTH) with docetaxel, carboplatin and trastuzumab (TCH) in HER2 positive early breast cancer patients: BCIRG 006 study. Presentation. San Antonio Breast Cancer Symposium 2005;Abstract 1.

Sledge GW et al. Adjuvant trastuzumab: Long-term results of E2198. San Antonio Breast Cancer Symposium 2006;Abstract 2075.

Stepanski EJ et al. Prevalence of insomnia and associated symptoms in patients with cancer. Proc ASCO 2007;Abstract 9098.

Winters L et al. Aromatase inhibitors and musculoskeletal pain in patients with breast cancer. Clin J Oncol Nurs 2007;11(3):433-9. Abstract

Table of Contents

Top of Page